|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn643726610 |
003 |
OCoLC |
005 |
20231117033147.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100625s1979 nyua ob 101 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OPELS
|d E7B
|d OCLCQ
|d OCLCF
|d OCLCQ
|d UIU
|d OCLCO
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d LEAUB
|d OCLCO
|d OCLCA
|d VLY
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 658185705
|a 1162310070
|
020 |
|
|
|a 0323151523
|
020 |
|
|
|a 9780323151528
|
020 |
|
|
|z 9780122499500
|
020 |
|
|
|z 0122499506
|
035 |
|
|
|a (OCoLC)643726610
|z (OCoLC)658185705
|z (OCoLC)1162310070
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QR185.8.L9
|b C37 1978
|
060 |
|
4 |
|a QW 575
|b C361a 1978
|
082 |
0 |
4 |
|a 616.07/93
|
111 |
2 |
|
|a Catharijne Conference on Immunology
|d (1978 :
|c Utrecht, Holland)
|
245 |
1 |
0 |
|a Antibody production in man :
|b in vitro synthesis and clinical implications : proceedings of the Catharijne Conference on Immunology held in Utrecht, Holland on March 15-18, 1978 /
|c edited by Anthony S. Fauci and Rudy Ballieux.
|
260 |
|
|
|a New York :
|b Academic Press,
|c 1979.
|
300 |
|
|
|a 1 online resource (xiv, 398 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Antibody Production in Man: In Vitro Synthesis and Clinical Implications; Copyright Page; Table of Contents; CONTRIBUTORS; PREFACE; CHAPTER 1. CONSIDERATION OF ANTIBODY DEFICIENCY DISEASES IN RELATION TO NORMAL B-CELL DEVELOPMENT; I. NORMAL DEVELOPMENT OF B CELLS; II. CONCLUSION; REFERENCES; CHAPTER 2. POKEWEED MITOGEN-INDUCED PFC RESPONSES OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES: REGULATION OF B-CELL TRIGGERING; I. INTRODUCTION; II. MATERIALS AND METHODS; III. RESULTS; IV. DISCUSSION; V. SUMMARY; REFERENCES
|
505 |
8 |
|
|a CHAPTER 3. INDUCTION OF ANTIBODY SYNTHESIS IN HUMAN LYMPHOCYTES FROM DIFFERENT ORGANS BY DIFFERENT PBA SUBSTANCESI. INTRODUCTION; II. OPTIMAL CONDITIONS FOR THE INDUCTION OF POLYCLONAL ANTIBODY RESPONSE BY LPS; III. LOCALIZATION OF B CELLS RESPONDING TO DIFFERENT BACTERIAL STRAINS WITH ANTIBODY FORMATION; IV. PBA PROPERTIES OF DIFFERENT BACTERIAL PREPARATIONS; V. AGE-DEPENDENT RESPONSE TO DIFFERENT BACTERIA IN ADENOID LYMPHOCYTES; VI. POLYCLONAL B CELL RESPONSE TO PPD IN CHILDREN WITH BCG INFECTION; VII. SUMMARY; REFERENCES
|
505 |
8 |
|
|a CHAPTER 4. THE PLAQUE-FORMING CELL RESPONSE OF HUMAN BLOOD LYMPHOCYTES COCULTIVATION OF LYMPHOCYTES FROM DIFFERENT INDIVIDUALSI. INTRODUCTION; II. METHODS; III. RESULTS; IV. DISCUSSION; REFERENCES; PART I: GENERAL DISCUSSION MITOGEN INDUCED B CELL ACTIVATION. I.; CHAPTER 5. T-T INTERACTIONS IN THE GENERATION OF HUMAN SUPPRESSOR EFFECTOR CELLS IN VITRO; I. INTRODUCTION; II. MATERIALS AND METHODS; III. RESULTS; IV. DISCUSSION; V. SUMMARY; REFERENCES; CHAPTER 6. BIOSYNTHESIS AND SECRETION OF IMMUNOGLOBULINS BY HUMAN PERIPHERAL BLOOD LYMPHOCYTES; I. INTRODUCTION; II. MATERIALS AND METHODS
|
505 |
8 |
|
|a Ill. RESULTSIV. DISCUSSION; REFERENCES; CHAPTER 7. ANTIGEN SPECIFIC AND ANTIGEN NONSPECIFIC TRIGGERING OF HUMAN B LYMPHOCYTES; I. INTRODUCTION; II. MATERIAL AND METHODS; III. RESULTS; REFERENCES; PART II: GENERAL DISCUSSION MITOGEN-INDUCED B-CELL ACTIVATION. II.; CHAPTER 8. ANTIGEN-INDUCED REGULATION OF THE PFC RESPONSE IN MAN; I. INTRODUCTION; II. MATERIALS AND METHODS; III. RESULTS AND DICUSSION; IV. SUMMARY; REFERENCES; CHAPTER 9. HUMAN B-CELL ACTIVATION IN VITRO: REGULATION BY ANTIGEN-SPECIFIC HUMAN SUPPRESSOR T CELLS; I. INTRODUCTION; II. MATERIALS AND METHODS; III. RESULTS
|
505 |
8 |
|
|a IV. DISCUSSIONV. SUMMARY; REFERENCES; CHAPTER 10. PRIMARY IN VITRO ANTIBODY RESPONSE TO TNP-PAA : CELLULAR BASIS; I. INTRODUCTION; II. MATERIALS AND METHODS; III. RESULTS; IV. DISCUSSION; REFERENCES; PART III: GENERAL DISCUSSION ANTIGEN INDUCED B CELL ACTIVATION. I.; CHAPTER 11. T -- B COLLABORATION IN THE IN VITRO AB RESPONSE TO DIPHTHERIA TOXOID; EVIDENCE FAVOURING A ROLE FOR B CELLS IN THE GENERATION OF T CELL HELP; REFERENCES; CHAPTER 12. ANTIGEN-DEPENDENT PFC INDUCTION IN CULTURES OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES; I. INTRODUCTION
|
520 |
|
|
|a Antibody Production in Man.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a B cells
|v Congresses.
|
650 |
|
0 |
|a Immunoglobulins
|v Congresses.
|
650 |
|
0 |
|a Human cell culture
|v Congresses.
|
650 |
|
0 |
|a Immune response
|x Regulation
|v Congresses.
|
650 |
|
0 |
|a Immunological deficiency syndromes
|v Congresses.
|
650 |
|
0 |
|a Immunoglobulins.
|
650 |
|
0 |
|a B cells
|x Congresses.
|
650 |
|
0 |
|a Immunoglobulins
|x Congresses.
|
650 |
|
0 |
|a Human cell culture
|x Congresses.
|
650 |
1 |
2 |
|a Antibody Formation
|0 (DNLM)D000917
|
650 |
|
6 |
|a Lymphocytes B
|0 (CaQQLa)201-0056955
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Immunoglobulines
|0 (CaQQLa)201-0008346
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Cellules humaines
|x Culture
|x Congr�es.
|
650 |
|
6 |
|a R�eaction immunitaire
|0 (CaQQLa)201-0018274
|x R�egulation
|0 (CaQQLa)201-0018274
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a D�eficit immunitaire, Syndromes de
|x Congr�es.
|
650 |
|
6 |
|a Lymphocytes B
|0 (CaQQLa)201-0056955
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Syndromes de d�eficit immunitaire
|0 (CaQQLa)201-0000187
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Anticorps
|x Production.
|0 (CaQQLa)201-0351594
|
650 |
|
7 |
|a B cells
|2 fast
|0 (OCoLC)fst00824789
|
650 |
|
7 |
|a Human cell culture
|2 fast
|0 (OCoLC)fst00962897
|
650 |
|
7 |
|a Immune response
|x Regulation
|2 fast
|0 (OCoLC)fst00967872
|
650 |
|
7 |
|a Immunoglobulins
|2 fast
|0 (OCoLC)fst00967961
|
650 |
|
7 |
|a Immunological deficiency syndromes
|2 fast
|0 (OCoLC)fst00967994
|
653 |
|
|
|a Man
|a B-cells Conference proceedings
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|0 (CStmoGRI)aatgf300027316
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Fauci, Anthony S.,
|d 1940-
|
700 |
1 |
|
|a Ballieux, R. E.
|
776 |
0 |
8 |
|i Print version:
|w (DLC) 79000928
|w (OCoLC)4664604
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780122499500
|z Texto completo
|